Cite
HARVARD Citation
Middleton, G. et al. (n.d.). Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial. Lancet oncology. 18 (4), pp. 486-499. [Online].